Schwann cells genetically modified to express neurotrophins promote spiral ganglion neuron survival in vitro

Neuroscience

Volumn 152, Issue 3, 2008, Pages 821-828

  Pettingill, L N ^a,b   Minter, R L ^b   Shepherd, R K ^a,b  

^a BIONIC EAR INSTITUTE   (Australia)

^b UNIVERSITY OF MELBOURNE   (Australia)

Author keywords

auditory; BDNF; ex vivo gene transfer; Ntf3

Indexed keywords

BRAIN DERIVED NEUROTROPHIC FACTOR; NEUROTROPHIC FACTOR; NEUROTROPHIN; NEUROTROPHIN 3;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CELL SURVIVAL; CONTROLLED STUDY; DRUG DELIVERY SYSTEM; GENE OVEREXPRESSION; HEARING IMPAIRMENT; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; SCHWANN CELL; SPIRAL GANGLION;

ANIMALS; ANIMALS, NEWBORN; BRAIN-DERIVED NEUROTROPHIC FACTOR; CELL COMMUNICATION; CELL SURVIVAL; CELLS, CULTURED; COCULTURE TECHNIQUES; GENE EXPRESSION REGULATION; GENE THERAPY; HEARING LOSS, SENSORINEURAL; NERVE DEGENERATION; NERVE GROWTH FACTORS; NEURONS, AFFERENT; NEUROTROPHIN 3; RATS; RATS, WISTAR; SCHWANN CELLS; SPIRAL GANGLION;

EID: 40949131357     PISSN: 03064522     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.neuroscience.2007.11.057     Document Type: Article

References (69)

1. Albright A.L., Awaad Y., Muhonen M., Boydston W.R., Gilmartin R., Krach L.E., Turner M., Zidek K.A., Wright E., Swift D., and Bloom K. Performance and complications associated with the synchromed 10-ml infusion pump for intrathecal baclofen administration in children. J Neurosurg 101 (2004) 64-68
2. Andrew JK, Geaney MS, Wise A, Pettingill LN, Richardson RT, Coco A, Skinner SJ, Shepherd RK (2007) Therapeutic potential of encapsulated neuroprotective cells in the cochlea. Proceedings of the IBRO World Congress of Neuroscience, Melbourne, Australia.
3. Blits B., Dijkhuizen P.A., Boer G.J., and Verhaagen J. Intercostal nerve implants transduced with an adenoviral vector encoding neurotrophin-3 promote regrowth of injured rat corticospinal tract fibers and improve hindlimb function. Exp Neurol 164 (2000) 25-37
4. Bottenstein J.E., and Sato G.H. Growth of a rat neuroblastoma cell line in serum-free supplemented medium. Proc Natl Acad Sci U S A 76 (1979) 514-517
5. Bowers W.J., Chen X., Guo H., Frisina D.R., Federoff H.J., and Frisina R.D. Neurotrophin-3 transduction attenuates cisplatin spiral ganglion neuron ototoxicity in the cochlea. Mol Ther 6 (2002) 12-18
6. Brigadski T., Hartmann M., and Lessmann V. Differential vesicular targeting and time course of synaptic secretion of the mammalian neurotrophins. J Neurosci 25 (2005) 7601-7614
7. Brockes J.P., Fields K.L., and Raff M.C. Studies on cultured rat Schwann cells. I. Establishment of purified populations from cultures of peripheral nerve. Brain Res 165 (1979) 105-118
8. Ernfors P., Duan M.L., ElShamy W.M., and Canlon B. Protection of auditory neurons from aminoglycoside toxicity by neurotrophin-3. Nat Med 2 (1996) 463-467
9. Ernfors P., Van De Water T., Loring J., and Jaenisch R. Complementary roles of BDNF and NT-3 in vestibular and auditory development. Neuron 14 (1995) 1153-1164
10. Farinas I., Jones K.R., Backus C., Wang X.Y., and Reichardt L.F. Severe sensory and sympathetic deficits in mice lacking neurotrophin-3. Nature 369 (1994) 658-661
11. Farinas I., Jones K.R., Tessarollo L., Vigers A.J., Huang E., Kirstein M., de Caprona D.C., Coppola V., Backus C., Reichardt L.F., and Fritzsch B. Spatial shaping of cochlear innervation by temporally regulated neurotrophin expression. J Neurosci 21 (2001) 6170-6180
12. Ferguson S.D., Michael N., and Frim D.M. Observations regarding failure of cerebrospinal fluid shunts early after implantation. Neurosurg Focus 22 (2007) E7
13. Fritzsch B., Pauley S., Matei V., Katz D.M., Xiang M., and Tessarollo L. Mutant mice reveal the molecular and cellular basis for specific sensory connections to inner ear epithelia and primary nuclei of the brain. Hear Res 206 (2005) 52-63
14. Fritzsch B., Tessarollo L., Coppola E., and Reichardt L.F. Neurotrophins in the ear: their roles in sensory neuron survival and fiber guidance. Prog Brain Res 146 (2004) 265-278
15. Frostick S.P., Yin Q., and Kemp G.J. Schwann cells, neurotrophic factors, and peripheral nerve regeneration. Microsurgery 18 (1998) 397-405
16. Gillespie L.N., Clark G.M., Bartlett P.F., and Marzella P.L. LIF is more potent than BDNF in promoting neurite outgrowth of mammalian auditory neurons in vitro. Neuroreport 12 (2001) 275-279
17. Gillespie L.N., Clark G.M., Bartlett P.F., and Marzella P.L. BDNF-induced survival of auditory neurons in vivo: Cessation of treatment leads to an accelerated loss of survival effects. J Neurosci Res 71 (2003) 785-790
18. Gillespie L.N., Clark G.M., and Marzella P.L. Delayed neurotrophin treatment supports auditory neuron survival in deaf guinea pigs. Neuroreport 15 (2004) 1121-1125
19. Grill R., Murai K., Blesch A., Gage F.H., and Tuszynski M.H. Cellular delivery of neurotrophin-3 promotes corticospinal axonal growth and partial functional recovery after spinal cord injury. J Neurosci 17 (1997) 5560-5572
20. Grill R.J., Blesch A., and Tuszynski M.H. Robust growth of chronically injured spinal cord axons induced by grafts of genetically modified NGF-secreting cells. Exp Neurol 148 (1997) 444-452
21. Hansen M., Zha X.M., Bok J., and Green S. Multiple distinct signal pathways, including an autocrine neurotrophic mechanism, contribute to the survival-promoting effect of depolarisation on spiral ganglion neurons in vitro. J Neurosci 21 (2001) 2256-2267
22. Hardie N.A., and Shepherd R.K. Sensorineural hearing loss during development: morphological and physiological response of the cochlea and auditory brainstem. Hear Res 128 (1999) 147-165
23. Hartmann M., Heumann R., and Lessmann V. Synaptic secretion of BDNF after high-frequency stimulation of glutamatergic synapses. EMBO J 20 (2001) 5887-5897
24. Hartnick C.J., Staecker H., Malgrange B., Lefebvre P.P., Liu W., Moonen G., and Van de Water T.R. Neurotrophic effects of BDNF and CNTF, alone and in combination, on postnatal day 5 rat acoustic ganglion neurons. J Neurobiol 30 (1996) 246-254
25. Haubensak W., Narz F., Heumann R., and Lessmann V. BDNF-GFP containing secretory granules are localized in the vicinity of synaptic junctions of cultured cortical neurons. J Cell Sci 111 Pt 11 (1998) 1483-1493
26. Hendriks W.T., Ruitenberg M.J., Blits B., Boer G.J., and Verhaagen J. Viral vector-mediated gene transfer of neurotrophins to promote regeneration of the injured spinal cord. Prog Brain Res 146 (2004) 451-476
27. Hu Y., Leaver S.G., Plant G.W., Hendriks W.T., Niclou S.P., Verhaagen J., Harvey A.R., and Cui Q. Lentiviral-mediated transfer of CNTF to Schwann cells within reconstructed peripheral nerve grafts enhances adult retinal ganglion cell survival and axonal regeneration. Mol Ther 11 (2005) 906-915
28. Hurley P.A., Crook J.M., and Shepherd R.K. Schwann cells revert to non-myelinating phenotypes in the deafened rat cochlea. Eur J Neurosci 26 (2007) 1813-1821
29. Kan P., and Kestle J. Lack of efficacy of antibiotic-impregnated shunt systems in preventing shunt infections in children. Childs Nerv Syst 23 (2007) 773-777
30. Lalwani A.K., Han J.J., Castelein C.M., Carvalho G.J., and Mhatre A.N. In vitro and in vivo assessment of the ability of adeno-associated virus-brain-derived neurotrophic factor to enhance spiral ganglion cell survival following ototoxic insult. Laryngoscope 112 (2002) 1325-1334
31. Leake P.A., and Hradek G.T. Cochlear pathology of long term neomycin induced deafness in cats. Hear Res 33 (1988) 11-33
32. Lessmann V., Gottmann K., and Malcangio M. Neurotrophin secretion: current facts and future prospects. Prog Neurobiol 69 (2003) 341-374
33. Marzella P.L., Gillespie L.N., Clark G.M., Bartlett P.F., and Kilpatrick T.J. The neurotrophins act synergistically with LIF and members of the TGF-beta superfamily to promote the survival of spiral ganglia neurons in vitro. Hear Res 138 (1999) 73-80
34. Menei P., Montero-Menei C., Whittemore S.R., Bunge R.P., and Bunge M.B. Schwann cells genetically modified to secrete human BDNF promote enhanced axonal regrowth across transected adult rat spinal cord. Eur J Neurosci 10 (1998) 607-621
35. Miller J.M., Chi D.H., O'Keeffe L.J., Kruszka P., Raphael Y., and Altschuler R.A. Neurotrophins can enhance spiral ganglion cell survival after inner hair cell loss. Int J Dev Neurosci 15 (1997) 631-643
36. Mirsky R., and Jessen K.R. The neurobiology of Schwann cells. Brain Pathol 9 (1999) 293-311
37. Morris J.K., Maklad A., Hansen L.A., Feng F., Sorensen C., Lee K.F., Macklin W.B., and Fritzsch B. A disorganized innervation of the inner ear persists in the absence of ErbB2. Brain Res 1091 (2006) 186-199
38. Motta F., Buonaguro V., and Stignani C. The use of intrathecal baclofen pump implants in children and adolescents: safety and complications in 200 consecutive cases. J Neurosurg 107 (2007) 32-35
39. Mou K., Adamson C.L., and Davis R.L. Time-dependence and cell-type specificity of synergistic neurotrophin actions on spiral ganglion neurons. J Comp Neurol 402 (1998) 129-139
40. Nakaizumi T., Kawamoto K., Minoda R., and Raphael Y. Adenovirus-mediated expression of brain-derived neurotrophic factor protects spiral ganglion neurons from ototoxic damage. Audiol Neurootol 9 (2004) 135-143
41. Pirvola U., Arumae U., Moshnyakov M., Palgi J., Saarma M., and Ylikoski J. Coordinated expression and function of neurotrophins and their receptors in the rat inner ear during target innervation. Hear Res 75 (1994) 131-144
42. Pirvola U., Ylikoski J., Palgi J., Lehtonen E., Arumae U., and Saarma M. Brain-derived neurotrophic factor and neurotrophin 3 mRNAs in the peripheral target fields of developing inner ear ganglia. Proc Natl Acad Sci U S A 89 (1992) 9915-9919
43. Praetorius M., Limberger A., Muller M., Lehner R., Schick B., Zenner H.P., Plinkert P., and Knipper M. A novel microperfusion system for the long-term local supply of drugs to the inner ear: implantation and function in the rat model. Audiol Neurootol 6 (2001) 250-258
44. Rejali D., Lee V.A., Abrashkin K.A., Humayun N., Swiderski D.L., and Raphael Y. Cochlear implants and ex vivo BDNF gene therapy protect spiral ganglion neurons. Hear Res 228 (2007) 180-187
45. Reynolds M.L., and Woolf C.J. Reciprocal Schwann cell-axon interactions. Curr Opin Neurobiol 3 (1993) 683-693
46. Richardson R.T., O'Leary S., Wise A., Hardman J., and Clark G. A single dose of neurotrophin-3 to the cochlea surrounds spiral ganglion neurons and provides trophic support. Hear Res 204 (2005) 37-47
47. Sciubba D.M., Lin L.M., Woodworth G.F., McGirt M.J., Carson B., and Jallo G.I. Factors contributing to the medical costs of cerebrospinal fluid shunt infection treatment in pediatric patients with standard shunt components compared with those in patients with antibiotic impregnated components. Neurosurg Focus 22 (2007) E9
48. Shepherd R.K., Coco A., and Epp S. Neurotrophins and electrical stimulation for protection and repair of spiral ganglion neurons following sensorineural hearing loss. Hearing Res (2008) [Epub ahead of print] doi:10.1016/j.heares.2007.12.005
49. Shepherd R.K., Coco A., Epp S.B., and Crook J.M. Chronic depolarisation enhances the trophic effects of BDNF in rescuing auditory neurons following a sensorineural hearing loss. J Comp Neurol 486 (2005) 145-158
50. Shepherd R.K., and Javel E. Electrical stimulation of the auditory nerve. I. Correlation of physiological responses with cochlear status. Hear Res 108 (1997) 112-144
51. Shepherd R.K., Roberts L.A., and Paolini A.G. Long-term sensorineural hearing loss induces functional changes in the rat auditory nerve. Eur J Neurosci 20 (2004) 3131-3140
52. Shinohara T., Bredberg G., Ulfendahl M., Pyykko I., Olivius N.P., Kaksonen R., Lindstrom B., Altschuler R., and Miller J.M. Neurotrophic factor intervention restores auditory function in deafened animals. Proc Natl Acad Sci U S A 99 (2002) 1657-1660
53. Sly D.J., Heffer L.F., White M.W., Shepherd R.K., Birch M.G., Minter R.L., Nelson N.E., Wise A.K., and O'Leary S.J. Deafness alters auditory nerve fibre responses to cochlear implant stimulation. Eur J Neurosci 26 (2007) 510-522
54. Staecker H., Gabaizadeh R., Federoff H., and Van De Water T.R. Brain-derived neurotrophic factor gene therapy prevents spiral ganglion degeneration after hair cell loss. Otolaryngol Head Neck Surg 119 (1998) 7-13
55. Staecker H., Liu W., Hartnick C., Lefebvre P., Malgrange B., Moonen G., and Van de Water T.R. NT-3 combined with CNTF promotes survival of neurons in modiolus-spiral ganglion explants. Neuroreport 6 (1995) 1533-1537
56. Stankovic K., Rio C., Xia A., Sugawara M., Adams J.C., Liberman M.C., and Corfas G. Survival of adult spiral ganglion neurons requires erbB receptor signaling in the inner ear. J Neurosci 24 (2004) 8651-8661
57. Terenghi G. Peripheral nerve regeneration and neurotrophic factors. J Anat 194 (1999) 1-14
58. Tobias C.A., Han S.S., Shumsky J.S., Kim D., Tumolo M., Dhoot N.O., Wheatley M.A., Fischer I., Tessler A., and Murray M. Alginate encapsulated BDNF-producing fibroblast grafts permit recovery of function after spinal cord injury in the absence of immune suppression. J Neurotrauma 22 (2005) 138-156
59. Tuszynski M.H., Gabriel K., Gage F.H., Suhr S., Meyer S., and Rosetti A. Nerve growth factor delivery by gene transfer induces differential outgrowth of sensory, motor, and noradrenergic neurites after adult spinal cord injury. Exp Neurol 137 (1996) 157-173
60. Tuszynski M.H., Weidner N., McCormack M., Miller I., Powell H., and Conner J. Grafts of genetically modified Schwann cells to the spinal cord: survival, axon growth, and myelination. Cell Transplant 7 (1998) 187-196
61. Weidner N., Blesch A., Grill R.J., and Tuszynski M.H. Nerve growth factor-hypersecreting Schwann cell grafts augment and guide spinal cord axonal growth and remyelinate central nervous system axons in a phenotypically appropriate manner that correlates with expression of L1. J Comp Neurol 413 (1999) 495-506
62. Wheeler E.F., Bothwell M., Schecterson L.C., and von Bartheld C.S. Expression of BDNF and NT-3 mRNA in hair cells of the organ of Corti: quantitative analysis in developing rats. Hear Res 73 (1994) 46-56
63. Whitlon D.S., Ketels K.V., Coulson M.T., Williams T., Grover M., Edpao W., and Richter C.P. Survival and morphology of auditory neurons in dissociated cultures of newborn mouse spiral ganglion. Neuroscience 138 (2006) 653-662
64. Winn S.R., Lindner M.D., Lee A., Haggett G., Francis J.M., and Emerich D.F. Polymer-encapsulated genetically modified cells continue to secrete human nerve growth factor for over 1 year in rat ventricles: behavioral and anatomical consequences. Exp Neurol 140 (1996) 126-138
65. Wise A.K., Richardson R., Hardman J., Clark G., and O'Leary S. Resprouting and survival of guinea pig cochlear neurons in response to the administration of the neurotrophins brain-derived neurotrophic factor and neurotrophin-3. J Comp Neurol 487 (2005) 147-165
66. Wissink T.F., Moes C., Beisel K.W., and Fritzsch B. Neurotrophins and hearing dysfunction: Comparing models to stop nerve fiber loss. Drug Discov Today 3 (2006) 391-396
67. Yagi M., Kanzaki S., Kawamoto K., Shin B., Shah P.P., Magal E., Sheng J., and Raphael Y. Spiral ganglion neurons are protected from degeneration by GDNF gene therapy. J Assoc Res Otolaryngol 1 (2000) 315-325
68. Yamagata T., Miller J.M., Ulfendahl M., Olivius N.P., Altschuler R.A., Pyykko I., and Bredberg G. Delayed neurotrophic treatment preserves nerve survival and electrophysiological responsiveness in neomycin-deafened guinea pigs. J Neurosci Res 78 (2004) 75-86
69. Ylikoski J., Pirvola U., Moshnyakov M., Palgi J., Arumae U., and Saarma M. Expression patterns of neurotrophin and their receptor mRNAs in the rat inner ear. Hear Res 65 (1993) 69-78